# Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors

> **NCT00003203** · PHASE2 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 168 (actual)

## Conditions studied

- Brain Tumors
- Central Nervous System Tumors
- Neuroblastoma

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** carboplatin
- **DRUG:** cisplatin
- **DRUG:** cyclophosphamide
- **DRUG:** vincristine sulfate
- **PROCEDURE:** adjuvant therapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003203
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-03
- **Primary completion:** 2007-10
- **Final completion:** 2012-03
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2013-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003203, "Carboplatin and Vincristine Plus Radiation Therapy Followed By Adjuvant Chemotherapy in Treating Young Patients With Newly Diagnosed CNS Embryonal Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00003203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*